Patient adherence to and tolerability of self-administered interferon β-1a using an electronic autoinjection device: a multicentre, open-label, phase IV study

BACKGROUND: Achieving good adherence to self-injected treatments for multiple sclerosis can be difficult. Injection devices may help to overcome some of the injection-related barriers to adherence that can be experienced by patients. We sought to assess short-term adherence to, and tolerability of,...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Lugaresi, Alessandra, Florio, Ciro, Brescia-Morra, Vincenzo, Cottone, Salvatore, Bellantonio, Paolo, Clerico, Marinella, Centonze, Diego, Uccelli, Antonio, di Ioia, Maria, De Luca, Giovanna, Marcellusi, Andrea, Paolillo, Andrea
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2012
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3368780/
https://ncbi.nlm.nih.gov/pubmed/22390218
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2377-12-7
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires